Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Open accessThe DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4+ and γδ+ T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17a−/− mice confirmed an essential role for IL-17A. Mechanistically, using ifnγ−/−, il10−/−, il10−/−il12p40−/−, and il10−/−il17a−/− mice and TGF-β blockade, we demonstrate that IL-17A–driven fibrosis is suppressed by IL-10 and facilitated by IFN-γ and IL-12/23p40. BLM-induced IL-17A production was also TGF-β dependent, and recombinant IL-17A–mediated fibrosis required TGF-β, suggesting cooperative roles for IL-17A and TGF-β in the development of fibrosis. Finally, we show that fibrosis induced by IL-1β, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1β were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A increases and stabilizes TGF-βRII expression on fibroblasts, thereby enhancing their sensitivity to TGF-β120”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [120]
In the citing paper
“the functions of IL-17 include stimulation of ECM production, collagen disposition, and mediation of TGF-β signaling (144).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
In the citing paper
“murine studies in which administration of IL-17A is sufficient to induce collagen accumulation and fibrotic lesions (144, 145)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 6×
“More recently, studies have also suggested important inflammatory activities for TGF, with TGF providing an integral differentiation signal for the develop ment of proinflammatory IL17A–secreting cells (Bettelli et al., 2006; Veldhoen et al., 2006).”
BackgroundResultInfluentialCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Self-citationIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 5×
“These observations also suggest that IL10 inhibits the development of BLMinduced fibrosis by targeting the proinflammatory IL23–IL17A pathway rather than the IL12–IFN axis.”
BackgroundInfluentialVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 3×
“However, recent studies demonstrated that TGF is also critically involved in the development of IL17A–producing lymphocytes (Bettelli et al., 2006; Veldhoen et al., 2006), which regulate the development of a variety of inflammatory and autoimmune diseases (Tesmer et al., 2008).”
BackgroundSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553 · cited 3×
“Similarly, IL1 can stimulate IL17A production (Sutton et al., 2009), and IL1 is a critical mediator of pulmonary fibrosis (Gasse et al., 2007).”
BackgroundMcGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520 · cited 3×
“Similar to previ ous studies (McGeachy et al., 2007; Stumhofer et al., 2007), IL10 was often coexpressed with IL17A and RoRt, sug gesting that Th17 cells may develop into IL10–secreting cells to limit Th17 effector function.”
ResultInduction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216 · cited 2×
“, 2006), which regulate the pathogenesis of a variety of autoimmune and inflammatory diseases (Bettelli et al., 2008).”
BackgroundTesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052 · cited 1×
“However, IL17A has been implicated in IL13– associated airway hyperreactivity (Nakae et al., 2002).”
BackgroundOrtiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019 · cited 1×
“These observations are consistent with studies that suggested IL10 could regulate the magnitude and effec tor function of Th17 responses (Fitzgerald et al., 2007; McGeachy et al., 2007; Chang et al., 2008).”
Result
Cited by
Items 301–400 of 751
Th-17 cytokines and interstitial lung involvement in systemic sclerosis
Rolla, G., Fusaro, E., Nicola, S., Bucca, C. B., Peroni, C. L., Parisi, S., Cassinis, M. C., Ferraris, A., Angelino, F., Heffler, E. M., et al. (2016) · Journal of Breath Research · doi:10.1088/1752-7155/10/4/046013 · Cited by 42
“In a murine model of pulmonary fibrosis, Wilson and Coll [28] and Pamela et al [27] showed that IL17A is required for the development of inflammation leading to fibrosis, thus suggesting the potential utility of targeting IL-17A in the treatment of IPF and other fibrotic diseases.”
BackgroundYadav, P., Ortega, J. G., Dabral, P., Tamaki, W., Chien, C., Chang, K.-C., Biswas, N., Pan, S., Nilsson, J., Yin, X., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188734 · Cited by 48
“We also found that fibroblast P2rx4 expression increased after bleomycin injury (Supplemental Figure 3H). of type 2 inflammation is later than the period when most collagen deposition has already occurred and, therefore, is less relevant to fibrogenesis (41).”
Zhou, X., Loomis-King, H. A., Gurczynski, S. J., Wilke, C. A., Konopka, K. E., Ptaschinski, C., Coomes, S. M., Iwakura, Y., van Dyk, L. F., Lukacs, N. W., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.85 · Cited by 41
IL-17 and related cytokines involved in systemic sclerosis: Perspectives
Gonçalves, R. S. G., Pereira, M. C., Dantas, A. T., de Almeida, A. R., Marques, C. D. L., Rêgo, M. J. B. D. M., Pitta, I. D. R., Duarte, Â. L. B. P., & Pitta, M. G. D. R. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1416467 · Cited by 41
Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis
Hu, S., Yang, M., Huang, S., Zhong, S.-J., Zhang, Q., Ding, H., Xiong, X., Hu, Z., & Yang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.818188 · Cited by 51
Russo, R. C., Savino, B., Mirolo, M., Buracchi, C., Germano, G., Anselmo, A., Zammataro, L. A., Pasqualini, F., Mantovani, A., Locati, M., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00233.2017 · Cited by 43
Wang, Y., Wang, X., Du, C., Wang, Z., Wang, J., Zhou, N., Wang, B., Tan, K., Fan, Y., & Cao, P. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1379521 · Cited by 48
Beneficial effects of bile acid receptor agonists in pulmonary disease models
Comeglio, P., Morelli, A., Adorini, L., Maggi, M., & Vignozzi, L. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1385760 · Cited by 43
“Engagingly, IL-1β also seems to be involved in bleomycin-induced pulmonary fibrosis [167].”
BackgroundInnate lymphoid cells in organ fibrosis
Mikami, Y., Takada, Y., Hagihara, Y., & Kanai∥, T. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.07.002 · Cited by 41
Wang, D., Gong, L., Li, Z., Chen, H., Xu, M., Rong, R., Zhang, Y., & Zhu, Q. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114522 · Cited by 42
Honeyman, L., Bazett, M., Tomko, T. G., & Haston, C. K. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-16 · Cited by 39
“Finally, miR-301a was demonstrated to contribute to T helper type 17 cell development in a model of autoimmune encephalomyelitis [40], and thus could function to alter this lymphocyte of importance to pulmonary fibrosis pathology [41].”
BackgroundBLT1 Mediates Bleomycin-Induced Lung Fibrosis Independently of Neutrophils and CD4+ T Cells
Lv, J., Xiong, Y., Li, W., Yang, W., Zhao, L., & He, R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600465 · Cited by 40
“However, U75302 treatment had no effect on the production of IL-13 and IL-17A in lung tissue homogenates (Fig.”
BackgroundInfluentialThe Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis
Raselli, T., Wyss, A., Alvarado, M. N. G., Weder, B., Mamie, C., Spalinger, M. R., van Haaften, W. T., Dijkstra, G. D. H., Sailer, A. W., Silva, P. H. I., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz039 · Cited by 41
Arterial wall fibrosis in Takayasu arteritis and its potential for therapeutic modulation
Misra, D. P., Singh, K., Sharma, A., & Agarwal, V. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1174249 · Cited by 41
“Upon stimulation of the PBMCs with anti-CD3/CD28, treatment with tacrolimus and tadalafil significantly reduced the levels of IL-6, IL-17A, IL-1b, and IL-10 in the culture supernatant than tacrolimus alone (34).”
BackgroundSilymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis
dos Santos, H. A. M., Lino, F. G., Rocha, C. C., Paiva, C. N., Branco, M. T. L. C., & Pyrrho, A. D. S. (2010) · Parasitology Research · doi:10.1007/s00436-010-2014-8 · Cited by 37
“Confirming these data, IL-13 rather than IL-1β/IL-17 was found to be responsible for hepatic fibrosis in schistosomiasis (Wilson et al. 2010).”
BackgroundZhang, X., Zhao, Y. S., Song, J., Yang, X., Zhang, J. J., Zhang, Y., & Li, R. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.7b05015 · Cited by 40
Li, Y., Song, F., Li, H., Li, Y., Li, J., He, Q., Zhang, D., Wang, F., Zhang, M., Zhao, H., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.145 · Cited by 37
Gouda, M. M., & Bhandary, Y. P. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27026 · Cited by 37
“The IL-17A mediated immune function attracts the neutrophils and macrophages to the site of inflammation.(16,61) IL-17A also attracts certain chemokines such as CXCL1, CXCL5, and CXCL12 to the inflammatory site.”
BackgroundOh, K., Seo, M. W., Kim, Y. W., & Lee, D. (2015) · Immune Network · doi:10.4110/in.2015.15.3.142 · Cited by 39
“The critical role of IL-17A in the pathogenesis of BLM-induced lung fibrosis has been reported previously (4-7).”
BackgroundNeutralization of Interleukin‐17 Attenuates Cholestatic Liver Fibrosis in Mice
Zhang, S., Huang, D., Weng, J., Huang, Y., Liu, S., Zhang, Q., Li, N., Wen, M., Zhu, G., Lin, F., et al. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12395 · Cited by 36
Inflammation accelerating intestinal fibrosis: from mechanism to clinic
Xin, S., Liu, X., He, C., Gao, H., Wang, B., Hua, R., Gao, L., Shang, H., Sun, F., & Xu, J. (2024) · European journal of medical research · doi:10.1186/s40001-024-01932-2 · Cited by 41
Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis
Arizmendi, N. G., Puttagunta, L., Chung, K. L., Davidson, C. E., Rey-Perra, J., Chao, D. V., Thébaud, B., Lacy, P., & Vliagoftis, H. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-71 · Cited by 37
“For example, IL-17A is required for BLM-induced fibrosis [29] and its main effect in the model may be recruitment of neutrophils.”
BackgroundSegawa, S., Goto, D., Iizuka, A., Kaneko, S., Yokosawa, M., Kondo, Y., Matsumoto, I., & Sumida, T. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12802 · Cited by 38
Interstitial Pneumonia in Psoriasis
Kawamoto, H., Hara, H., Minagawa, S., Numata, T., Araya, J., Kaneko, Y., Umezawa, Y., Asahina, A., Nakagawa, H., & Kuwano, K. (2018) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2018.07.006 · Cited by 38
Hobo, A., Harada, K., Maeda, T., Uchiyama, M., Irisawa, R., Yamazaki, M., & Tsuboi, R. (2018) · Experimental Dermatology · doi:10.1111/exd.13816 · Cited by 36
Lymphocytes: Versatile Participants in Acute Kidney Injury and Progression to Chronic Kidney Disease
Cao, C., Yao, Y., & Zeng, R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.729084 · Cited by 37
Shimodaira, T., Matsuda, K., Uchibori, T., Sugano, M., Uehara, T., & Honda, T. (2018) · Cytokine · doi:10.1016/j.cyto.2018.04.025 · Cited by 39
“oalveolar lavage fluid (BALF) obtained from patients with idiopathic pulmonary fibrosis (IPF) or IPF-model mice [6,7,13,14].”
BackgroundRusso, R. C., & Ryffel, B. (2024) · Cells · doi:10.3390/cells13242058 · Cited by 39
“IL-17A, a well-established fibrogenic inducer in murine pulmonary fibrosis models and IPF samples [388,389], activates CCR6+ Th17 lymphocytes, responding to CCL20 levels [390].”
An aging bone marrow exacerbates lung fibrosis by fueling profibrotic macrophage persistence
Farhat, A., Radhouani, M., Deckert, F., Zahalka, S., Pimenov, L., Fokina, A., Hakobyan, A., Oberndorfer, F., Brösamlen, J., Hladik, A., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adk5041 · Cited by 38
Zhao, L., Mu, B., Zhou, R., Cheng, Y., & Huang, C. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13463 · Cited by 42
Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice
Li, J., Liu, L., Zhao, Q., & Chen, M. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05969-w · Cited by 35
“Another study showed that IL-17A induced lung fibrosis and was TGF-β dependent [22], suggesting cooperative roles of IL-17A and TGF-β in development of fibrosis.”
BackgroundImmune Dysregulation in IgG4-Related Disease
Liu, J., Yin, W., Westerberg, L. S., Lee, P. P. W., Gong, Q., Chen, Y., Dong, L., & Liu, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738540 · Cited by 41
Xiao, H., Peng, L., Jiang, D., Liu, Y., Zhu, L., Li, Z., Geng, J., Xie, B., Huang, X., Wang, J., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17600 · Cited by 37
Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes
Ebrahimpour, A., Shrestha, S., Bonnen, M., Eissa, N. T., Raghu, G., & Ghebre, Y. T. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252650 · Cited by 36
“Upregulation of classic inflammatory molecules such as soluble TNF-a, IL1b, and NFkB have been reported in the bleomycin model of lung injury and IPF patients (Serrano-Mollar et al., 2003; Oikonomou et al., 2006; Wilson et al., 2010).”
BackgroundKim, S. H., White, Z., Gainullina, A., Kang, S., Kim, J., Dominguez, J. R., Choi, Y., Cabrera, I., Plaster, M., Takahama, M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.004 · Cited by 37
Rajasekaran, S., Reddy, N. M., Zhang, W., & Reddy, S. P. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-381 · Cited by 34
“More importantly, in mouse models, exogenous administration of recombinant Il1β induced high degree of bleomycin-induced fibrosis, and specific blockade of Il1r1 markedly reduced bleomycininduced inflammation [16,17].”
BackgroundZhang, R., Chen, S., Chen, L., Ye, L., Jiang, Y., Peng, H., Guo, Z., Li, M., Jiang, X., Guo, P., et al. (2022) · Particle and Fibre Toxicology · doi:10.1186/s12989-022-00483-w · Cited by 37
“It has been demonstrated that IL-17A functions in cooperation with other cytokines including IL-6, GM-CSF, and IL-8 to regulate the immune microenvironment by enhancing myeloid-derived cells recruitment [33, 36], as well as facilitating tissue remodeling [32, 37].”
BackgroundExternalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27
Riehl, D., Sharma, A., Roewe, J., Murke, F., Ruppert, C., Eming, S. A., Bopp, T., Kleinert, H., Radsak, M. P., Colucci, G., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215421120 · Cited by 34
Control of inflammatory heart disease by CD4+ T cells
Barin, J. G., & Čiháková, D. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12134 · Cited by 34
Jupelli, M., Shimada, K., Chiba, N., Slepenkin, A. V., Alsabeh, R., Jones, H. D., Peterson, E. M., Chen, S., Arditi, M., & Crother, T. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077447 · Cited by 38
“inducing lung fibrosis [51,52], however, we did not find any”
Interleukin-17A antagonist attenuates radiation-induced lung injuries in mice
Wang, B.-Z., Wang, L.-P., Han, H., Cao, F.-L., Li, G.-Y., Xu, J.-L., Wang, X.-W., & Wang, L.-X. (2014) · Experimental Lung Research · doi:10.3109/01902148.2013.872210 · Cited by 33
“IL-17A is expressed fibrosis-related diseases, mediating bleomycin- and IL-1β-induced pulmonary fibrosis in mice [19].”
BackgroundChronic allograft dysfunction: A model disorder of innate immunity
Land, W. G. (2013) · Biomedical Journal · doi:10.4103/2319-4170.117622 · Cited by 36
Gupta, P. K., Wagner, S. R., Wu, Q., & Shilling, R. A. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0154oc · Cited by 34
New therapeutics based on emerging concepts in pulmonary fibrosis
Sontake, V., Gajjala, P. R., Kasam, R. K., & Madala, S. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1552262 · Cited by 34
“T cell responses have been shown to mediate tissue damage and fibrosis in IPF [84,85].”
BackgroundSelf-citationKurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways
Park, S.-J., Kim, T., Lee, K., Kang, M.-A., Jang, H., Ryu, H. W., Oh, S., & Lee, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168388 · Cited by 35
“During the development of bleomycin-induced fibrosis, IL-17 showed a synergistic effect with TGF-β in promoting collagen production [17].”
BackgroundThe role of PD-1/PD-L1 axis in idiopathic pulmonary fibrosis: Friend or foe?
Jiang, A., Liu, N., Wang, J., Zheng, X., Ren, M., Zhang, W., & Yao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1022228 · Cited by 34
“A previous study also observed elevated interleukin17A (IL17A), which is the typical cytokine of Th17 cells in the bronchoalveolar lavage (BALF) of IPF patients (53).”
BackgroundVultaggio, A., Nencini, F., Pratesi, S., Maggi, L., Guarna, A., Annunziato, F., Romagnani, S., Parronchi, P., & Maggi, E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002398 · Cited by 33
Rikkunshito ameliorates bleomycin-induced acute lung injury in a ghrelin-independent manner
Tsubouchi, H., Yanagi, S., Miura, A., Iizuka, S., Mogami, S., Yamada, C., Hattori, T., & Nakazato, M. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00096.2013 · Cited by 34
“With regard to the mechanisms underlying the mitigation of lung fibrosis in RKT-treated mice, we observed a significant reduction of TGF- and IL-1 in the BALF and lung tissues of the BLM/RKT mice.”
InfluentialMa, H., Xu, J., Liu, X., Zhu, Y., Gao, B., Karin, M., Tsukamoto, H., Jeste, D. V., Grant, I., Roberts, A. J., et al. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0097-3 · Cited by 34
Yombo, D. J. K., Mentink‐Kane, M. M., Wilson, M. S., Wynn, T. A., & Madala, S. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009145 · Cited by 33
“The preparation of airway-infiltrating cells in the BALF and the differential cell count were performed as described previously with slight modifications (46, 64).”
MethodSelf-citationAutoreactive T and B Cells Induce the Development of Bronchus-Associated Lymphoid Tissue in the Lung
Shilling, R. A., Williams, J. W., Perera, J. F., Berry, E. L., Wu, Q., Cummings, O. W., Sperling, A. I., & Huang, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0065oc · Cited by 32
Roeleveld, D. M., van Nieuwenhuijze, A. E. M., van den Berg, W. B., & Koenders, M. I. (2013) · BioDrugs · doi:10.1007/s40259-013-0035-4 · Cited by 34
IL-17 in the Rheumatologist’s Line of Sight
Truchetet, M., Mossalayi, M. D., & Boniface, K. (2013) · BioMed Research International · doi:10.1155/2013/295132 · Cited by 32
“However, after the onset of arthritis, neutralization of IL-17 prevents any further increase of the disease but does not reduce the arthritis score [140].”
BackgroundBone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17
Zheng, L., Chu, J., Shi, Y., Zhou, X., Tan, L., Li, Q., Cui, L., Han, Z., Han, Y., & Fan, D. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-46 · Cited by 32
“It has been found that IL-17 plays a critical role in pulmonary fibrosis [26] and psoriasis [27].”
BackgroundTargeting anti‐aging protein sirtuin (Sirt) in the diagnosis of idiopathic pulmonary fibrosis
Shaikh, S. B., Prabhu, A., & Bhandary, Y. P. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28033 · Cited by 32
Mleczko, M., Gerkowicz, A., & Krasowska, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031767 · Cited by 31
Anipindi, V. C., Bagri, P., Dizzell, S. E., Jiménez‐Saiz, R., Jordana, M., Snider, D. P., Stämpfli, M. R., & Kaushic, C. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900040 · Cited by 32
Sirolimus-eluting airway stent reduces profibrotic Th17 cells and inhibits laryngotracheal stenosis
Motz, K., Lina, I. A., Samad, I., Murphy, M. K., Duvvuri, M., Davis, R. J., Gelbard, A. H., Chung, L., Chan‐Li, Y., Collins, S. L., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.158456 · Cited by 33
“158456 is upregulated and demonstrated to be pathologic in multiple models of lung fibrosis (27, 36, 40, 41).”
BackgroundPulmonary fibrosis and type-17 immunity
Senoo, S., Higo, H., Taniguchi, A., Kiura, K., Maeda, Y., & Miyahara, N. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.05.005 · Cited by 35
Mavropoulos, Α., Liaskos, C., Simopoulou, T., Bogdanos, D. P., & Sakkas, L. I. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.04.013 · Cited by 30
Leal, M. P., Brochetti, R. A., Ignácio, A., Câmara, N. O. S., da Palma, R. K., de Oliveira, L. V. F., da Silva, D. D. F. T., & Lino‐dos‐Santos‐Franco, A. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.03.016 · Cited by 33
Ramani, K., Tan, R. J., Zhou, D. F., Coleman, B. M., Jawale, C. V., Liu, Y., & Biswas, P. S. (2018) · Mediators of Inflammation · doi:10.1155/2018/5103672 · Cited by 33
Kidzeru, E. B., Lebeko, M., Sharma, J. R., Lucia, N., Adeola, H. A., Ndlovu, H., Khumalo, N. P., & Bayat, A. (2023) · Experimental Dermatology · doi:10.1111/exd.14734 · Cited by 30
Majeed, B. A., Tawinwung, S., Eberson, L. S., Secomb, T. W., Larmonier, N., & Larson, D. F. (2014) · International Journal of Hypertension · doi:10.1155/2014/126365 · Cited by 31
Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis
Hasegawa, M., Fujimoto, M., Matsushita, T., Hamaguchi, Y., & Takehara, K. (2012) · Rheumatology · doi:10.1093/rheumatology/kes258 · Cited by 30
Autophagy and Obesity-Related Lung Disease
Pabón, M. A., Ma, K. C., & Choi, A. M. K. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0045ps · Cited by 34
Ji, W.-J., Ma, Y.-Q., Zhang, X., Zhang, L., Zhang, Y.-D., Su, C.-C., Xiang, G.-A., Zhang, M.-P., Lin, Z.-C., Wei, L.-Q., et al. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0006 · Cited by 30
Li, F., Han, F., Li, H., Zhang, J., Qiao, X., Shi, J., Li, Y., Dong, J., Luo, M., Wei, J., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.06.032 · Cited by 30
Murray, L. A., Rubinowitz, A. N., & Herzog, E. L. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283588de4 · Cited by 33
Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis
Kida, T., Ayabe, S., Omori, K., Nakamura, T., Maehara, T., Aritake, K., Urade, Y., & Murata, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167729 · Cited by 32
The roles of IL-17C in T cell-dependent and -independent inflammatory diseases
Yamaguchi, S., Nambu, A., Numata, T., Yoshizaki, T., Narushima, S., Shimura, E., Hiraishi, Y., Arae, K., Morita, H., Matsumoto, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34054-x · Cited by 31
Cheng, D., Lian, W., Wang, T., Xi, S., Jia, X., Li, Z., Xiong, H., Wang, Y., Sun, W., Zhou, S., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133713 · Cited by 29
Oliveira, F. M. S., Matias, P. H. D. P., Kraemer, L. R., Gazzinelli-Guimarães, A. C., Vieira-Santos, F., Amorim, C. C. O., Nogueira, D. S., de Freitas, C. S., Caliari, M. V., Bartholomeu, D. C., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007896 · Cited by 30
“In evaluating the production of IL-4, which is a cytokine already characterized in Th2 immune response present in helminthic infections [24,28] and pulmonary fibrosis [1,6,36], we observed a significant increase in IL-4 in the A.”
BackgroundInfluentialIL10 trains macrophage profibrotic function after lung injury
Bhattacharyya, A., Boostanpour, K., Bouzidi, M. S., Magee, L., Chen, T. Y., Wolters, R. M., Torre, P., Pillai, S. K., & Bhattacharya, M. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00458.2021 · Cited by 33
Gowdy, K. M., Nugent, J. L., Martinu, T., Potts, E. N., Snyder, L. D., Foster, W. M., & Palmer, S. M. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0131oc · Cited by 29
“Recent studies have implicated Th17 cells as an important T cell subset in transplant-related lung disease (38–40) and models of pulmonary fibrosis (41, 42).”
BackgroundLee, S. J., Park, J., Lee, J., Jeong, Y., Song, J. A., Lee, K., & Kim, D. (2016) · Journal of Toxicologic Pathology · doi:10.1293/tox.2015-0067 · Cited by 28
The Chinese Herbal Medicine Formula mKG Suppresses Pulmonary Fibrosis of Mice Induced by Bleomycin
Gao, Y., Yao, L.-F., Zhao, Y., Wei, L.-M., Guo, P. C., Yu, M., Cao, B., Tan, L., Chen, H., & Zou, Z. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020238 · Cited by 28
Vaccinia vaccine–based immunotherapy arrests and reverses established pulmonary fibrosis
Collins, S. L., Chan‐Li, Y., Oh, M. H., Vigeland, C. L., Limjunyawong, N., Mitzner, W., Powell, J. D., & Horton, M. R. (2016) · JCI Insight · doi:10.1172/jci.insight.83116 · Cited by 28
Expression of Interleukin-17A in Lung Tissues of Irradiated Mice and the Influence of Dexamethasone
Wang, L., Wang, Y.-W., Wang, B., Sun, G., Wang, X., & Xu, J. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/251067 · Cited by 29
Li, Y., Lu, H., Lv, X., Tang, Q., Li, W., Zhu, H., & Long, Y. (2018) · Inflammation · doi:10.1007/s10753-018-0862-z · Cited by 27
Creyns, B., Cremer, J., Hoshino, T., Geboes, K. J., Hertogh, G. D., Ferrante, M., Vermeire, S., Ceuppens, J. L., Assche, G. V., & Breynaert, C. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46472-6 · Cited by 30
Essential role of IL-23 in the development of acute exacerbation of pulmonary fibrosis
Senoo, S., Taniguchi, A., Itano, J., Oda, N., Morichika, D., Fujii, U., Guo, L., Sunami, R., Kanehiro, A., Tokioka, F., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00582.2020 · Cited by 30
Emerging drugs for idiopathic pulmonary fibrosis
Selman, M., Pardo, A., Richeldi, L., & Cerri, S. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.565049 · Cited by 29
“More recently, several interleukins, that is, IL-17A, have been found to be increased in BAL fluids from IPF patients, and appeared to be critical for the development of experimental lung fibrosis [28].”
BackgroundInterleukin-38 overexpression prevents bleomycin-induced mouse pulmonary fibrosis
Xu, Z., Yuan, X., Gao, Q., Li, Y., & Li, M. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01920-3 · Cited by 26
Metabolic fingerprinting of systemic sclerosis: a systematic review
Morales-González, V., Galeano-Sánchez, D., Covaleda-Vargas, J. E., Rodríguez, Y., Monsalve, D. M., Pardo-Rodriguez, D., Cala, M. P., Acosta‐Ampudia, Y., & Ramírez-Santana, C. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1215039 · Cited by 27
“Some studies claimed that Th17 cells induced type I collagen synthesis and secretion to promote fibrosis of murine SSc models (Wilson et al., 2010; Lei et al., 2016; Ramani and Biswas, 2019); however, other researchers propose Th17 cells decrease type I collagen production by dermal fibroblasts (Brembilla et al.”
ResultT-bet controls severity of hypersensitivity pneumonitis
Abdelsamed, H. A., Desai, M., Nance, S. C., & Fitzpatrick, E. A. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-15 · Cited by 28
Hasegawa, M., & Takehara, K. (2012) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.03.014 · Cited by 26
“The critical roles of IL-17A have been demonstrated in sclerodermatous chronic graft-versus-host disease (143).”
InfluentialMonnier, J., & Zabel, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099350 · Cited by 28
Functional genomic screen identifies novel mediators of collagen uptake
Lee, T., McKleroy, W., Khalifeh‐Soltani, A., Sakuma, S., Lazarev, S., Riento, K., Nishimura, S. L., Nichols, B. J., & Atabai, K. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0382 · Cited by 26
“Although many of the molecular pathways that induce excess collagen production have been described (Ratziu et al., 1998; Munger et al., 1999; Tager et al., 2008; Wilson et al., 2010; Li et al., 2011), there is a limited understanding of the degradation pathways that normally serve to limit or prevent the development o…”
Malecka, A. A., Wang, Q., Shah, S., Sutavani, R. V., Spendlove, I., Ramage, J. M., Greensmith, J., Franks, H., Gough, M. J., Saalbach, A., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1015-474r · Cited by 26
“As IL-17 is a critical factor driving postradiation fibrosis [24], this work identifies a potential mechanism for the pathologic consequences of radiation and chemotherapy [25, 61].”
BackgroundKwan, P. O., Ding, J., & Tredget, E. E. (2015) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000271 · Cited by 26
The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
Hanaka, T., Kido, T., Noguchi, S., Yamada, S., Noguchi, H., Guo, X., Nawata, A., Wang, K., Oda, K., Takaki, T., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-1032-2 · Cited by 26
“Reportedly, IL-17A is involved in the pathogenesis of BLM-induced PF [35], and early IL-17A axis leads to pulmonary inflammation and fibrosis in the late phase [36].”
BackgroundLo, C., Wang, C., Wang, C., Chen, C., Huang, H.-Y., Chung, F., Huang, Y., Lin, C., Lee, C.-S., Lin, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905727 · Cited by 27
“Neutrophils and IL-17 have been associated with the development of lung fibrosis in animal models (23, 24).”
BackgroundKhalil, R. G., Ibrahim, A. M., & Bakery, H. H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109415 · Cited by 25
Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis
Hosseinzadeh, A., Pourhanifeh, M. H., Amiri, S., Sheibani, M., Irilouzadian, R., Reiter, R. J., & Mehrzadi, S. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00554-5 · Cited by 26
“The presence of this cytokine may be an essential factor in the development of pulmonary fibrosis [188].”
Pulmonary Vaccination as a Novel Treatment for Lung Fibrosis
Collins, S. L., Chan‐Li, Y., Hallowell, R. W., Powell, J. D., & Horton, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031299 · Cited by 28
“Finally, IL-17 has also been shown to play a role in the pathogenesis of bleomycin-induced lung fibrosis [20].”
BackgroundResultInfluentialMadala, S. K., Edukulla, R., Davis, K. R., Schmidt, S., Davidson, C. R., Kitzmiller, J. A., Hardie, W. D., & Korfhagen, T. R. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-51 · Cited by 27
“Bleomycin-induced pulmonary fibrosis was performed as described earlier with few modifications [24].”
Self-citationConte, E., Iemmolo, M., Fagone, E., Gili, E., Fruciano, M., Genovese, T., Esposito, E., Cuzzocrea, S., & Vancheri, C. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.02.001 · Cited by 25
Advances in understanding the immunopathology of sarcoidosis and implications on therapy
Cinetto, F., & Agostini, C. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1181541 · Cited by 26
“The involvement of IL-17A in the development of fibrosis was recently demonstrated in a murine model of bleomycin (BLM)-induced PF [65].”
BackgroundThiéblemont, N., Witko‐Sarsat, V., & Ariel, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12990 · Cited by 26
Metadata
- Authors
- Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 3
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-02-22
- Volume
- 207
- Issue
- 3
- Pages
- 535-552
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2839145
- OpenAlex
- W2095715691
- Cited by
- 730
- References
- 84
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 68 · 2023: 45 · 2022: 47 · 2021: 39 · 2020: 38 · 2019: 51 · 2018: 47 · 2017: 48 · 2016: 42 · 2015: 42 · 2014: 40 · 2013: 57 · 2012: 45
- FWCI
- 41.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, IL-17A, bleomycin-induced lung injury, IL-1β, pulmonary fibrosis, TGF-beta, IL-10, interferon-gamma, IL-12/23p40, γδ T cells, CD4+ T cells, neutrophilia, Schistosoma mansoni eggs, bronchoalveolar lavage, IL-17A blockade
- MeSH terms
- Animals, Bleomycin, Interferon-gamma, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Schistosoma mansoni, Schistosomiasis mansoni, CD4-Positive T-Lymphocytes, Interleukin-10, Mice, Knockout, Interleukin-13, Interleukin-17, Mice, Interleukin-1beta, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.